Clinical Trials

Pharmaceutical Filtration Market Size Worth USD 43.96 Billion in 2030 | CAGR: 10.51%

New Delhi, August 18, 2023:  According to Adroit Market Research, the Global Pharmaceutical Filtration Market size was estimated at USD 19.99 billion…

1 year ago

Optimus becomes the First Company to Conclude Study of Molnupiravir Phase 3 Clinical Trial with Promising Results

Hyderabad, November 03, 2021: Optimus Group has announced the successful completion of the much-awaited Molnupiravir Oral Capsule Phase 3 Clinical Trial.…

3 years ago

India Tops the Chart for Approved Biosimilars and Clinical Trials Surpassing USA and Europe: 10th Annual Pharma IPR India Conference

Pharma IPR India Conference is one of India’s leading Pharma events showcasing innovative trends in the Intellectual property (IP) space,…

3 years ago

Amidst the ongoing Covid-19 pandemic ISSAR Pharma announces out-licensing of its peptide-based NCEs

ISSAR Pharma, the only company in India which focuses on research and development of New Chemical Entities (NCE), is licensing…

4 years ago

Molnupiravir for treating Covid-19 at Yashoda Hospitals Somajiguda, Hyderabad – Phase 3 trials

New Delhi, May 22, 2021: Hyderabad based Yashoda Hospitals in their Somajigida unit will start Phase III Trials in association…

4 years ago

LANXESS plans to expand capacity for Oxone monopersulfate – a main active ingredient for disinfectants

·         Production increase of around 50 percent targeted ·         Investment amount in the lower double-digit million euro range ·         Significant increase in demand…

4 years ago

Eisai Presents Latest Data of Phase I Clinical Trial on Liposomal Formulation of Anti-Cancer Agent Halaven (Eribulin) at ESMO Virtual Congress 2020

Tokyo, September 18, 2020: Eisai Co., Ltd. has announced that the latest results from the cohort targeting patients with HER2-negative…

4 years ago

CORONA Remedies picks up stake in La Chandra Pharmalab

The alliance will help the two companies leverage each other's strengths Ahmedabad, September 08, 2020: Ahmedabad-based pharma major CORONA Remedies…

4 years ago

Fujitsu and Tokyo Shinagawa Hospital Embark on Joint Research and Development of AI Technology to Support Diagnosis of COVID-19 Pneumonia

- Fujitsu and Tokyo Shinagawa Hospital to develop an AI-based technology to facilitate the diagnosis of COVID-19 pneumonia - The…

4 years ago